Amid the burgeoning imaging volumes and ongoing radiologist shortage, this author suggests that more active involvement by radiologists in the creation and development of AI models could go a long way.
|Articles|February 19, 1997
Radiotracer firms launch MoAb agents
Two monoclonal-antibody-based radiopharmaceuticals that receivedFood and Drug Administration approval last year were launchedearly this month. Cytogen of Princeton, NJ, and marketing partnerC.R. Bard of Murray Hill, NJ, began selling their
Advertisement
Two monoclonal-antibody-based radiopharmaceuticals that receivedFood and Drug Administration approval last year were launchedearly this month. Cytogen of Princeton, NJ, and marketing partnerC.R. Bard of Murray Hill, NJ, began selling their ProstaScintagent for detecting prostate cancer (SCAN 11/6/96), while Du PontMerck Radiopharmaceuticals of North Billerica, MA, began sellingVerluma, a small-cell lung cancer imaging agent developed by NeoRxof Seattle (SCAN 9/25/96).
Advertisement
Related to this article
In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the evolution, research and pearls for ablation procedures, and emerging considerations for histotripsy in the realm of interventional oncology.
New research found that the late arterial phase, which accounts for approximately 40 percent of CT radiation dosing in cases involving acute abdominal pain, offered no exclusive findings that had an impact on clinical care.
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Perspective and experience enable us to discern a reasonable explanation prior to boarding a rollercoaster of overreaction.
Catch up on the top radiology content of the past week.
Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).
Catch up on the most-well viewed radiology content in October 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Interventional Radiology in Focus: Emerging Concepts with Ablation and Histotripsy in Interventional Oncology
2
Key Features with EPNI on CT May More than Double Mortality Risk in Pancreatic Cancer
3
Is Late Arterial Phase CT Necessary for Undifferentiated Acute Abdominal Pain?
4
Could a CCTA-Guided Approach Provide a Viable Alternative to Intravascular Ultrasound Guidance for PCI Procedures?
5